Skip to main navigation
Accessibility Recite Me
MeiraGTx
  • Company
    • About Us
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Technology & Innovation
    • Riboswitch In-vivo Delivery Platform
    • Next-Generation Vector Optimization
    • End-to-end Manufacturing Ecosystem
    • Posters & Publications
  • Programs & Pipeline
    • Pipeline
    • Parkinson’s Disease
    • Xerostomia (dry mouth)
    • AIPL1 Retinal Dystrophy
  • Patients & Families
    • Commitment to Patients
    • Parkinson’s Disease
    • Radiation-Induced Xerostomia
    • Inherited Retinal Disease
    • Rare Diseases
  • Investors & Media
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Join Our Team
Banner

Investors & Media

Investors & Media

  • Overview
  • News Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Financial Information
  • Investor Resources

Stockholder Tools

  • Print Page
  • RSS Feeds
  • Email Page
  • Email Alerts

Documents & Charters

Documents & Charters

Governance Documents

Code of Business Conduct and Ethics
Corporate Governance Guidelines

Committee Charters

Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
Science and Technology Committee Charter

Investors & Media

  • Overview
  • News Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
  • Financial Information
  • Investor Resources

Stockholder Tools

  • Print Page
  • RSS Feeds
  • Email Page
  • Email Alerts
MeiraGTx

©  MeiraGTx Limited. All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions
  • Sitemap
  • Company
  • Technology & Innovation
  • Programs & Pipeline
  • Patients & Families
  • Investors & Media
  • Join Our Team
  • Twitter
  • LinkedIn